Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C
- PMID: 22911171
- DOI: 10.1007/s00535-012-0656-2
Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C
Abstract
Background: Thrombocytopenia is a marked feature of chronic liver disease and cirrhosis. We tried to clarify whether an accumulation of platelets in the liver contributes to thrombocytopenia and liver fibrosis in chronic liver disease.
Methods: Thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (HCC) with hepatitis C virus infection were included. The locations of platelets and Kupffer cells and the expression of platelet-derived growth factor (PDGF) receptor-β and smooth muscle actin (SMA) were identified by immunohistochemistry. Perisinusoidal mesenchymal cells that express PDGF receptor-β and SMA were interpreted as transformed hepatic stellate cells (HSCs).
Results: Patients with cirrhosis had a more extensive platelet area in the liver compared to controls (5601 ± 5611 vs. 564 ± 361 μm(2), p = 0.02), although the blood platelet count significantly decreased along with the progression of liver fibrosis. In cirrhotic liver, most platelets were present in the sinusoidal space of the periportal area with inflammation, where HSCs expressing PDGF receptor-β were frequently observed. In addition, the platelet and Kupffer cell areas were significantly smaller in cancerous tissue than those in noncancerous tissues (platelet area: 492 ± 823 vs. 3643 ± 4055 μm(2), p = 0.001; Kupffer cell area: 450 ± 841 vs. 3012 ± 3051 μm(2), p = 0.001).
Conclusions: The accumulation of platelets in the liver with chronic hepatitis may be involved in thrombocytopenia and liver fibrosis through the activation of HSCs. In addition, our findings also indicate that both platelets and Kupffer cells decrease in HCC tissues.
Similar articles
-
Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.J Gastroenterol. 2010 Aug;45(8):876-84. doi: 10.1007/s00535-010-0233-5. Epub 2010 Mar 26. J Gastroenterol. 2010. PMID: 20339877
-
Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.Kaohsiung J Med Sci. 2013 Jul;29(7):385-95. doi: 10.1016/j.kjms.2012.11.007. Epub 2013 Jan 12. Kaohsiung J Med Sci. 2013. PMID: 23768703
-
Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.J Gastrointestin Liver Dis. 2009 Jun;18(2):163-7. J Gastrointestin Liver Dis. 2009. PMID: 19565045
-
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.J Gastroenterol. 2018 Jul;53(7):819-826. doi: 10.1007/s00535-017-1425-z. Epub 2018 Jan 9. J Gastroenterol. 2018. PMID: 29318378 Review.
-
Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review).Mol Med Rep. 2020 Nov;22(5):4116-4124. doi: 10.3892/mmr.2020.11516. Epub 2020 Sep 17. Mol Med Rep. 2020. PMID: 33000255 Review.
Cited by
-
Measuring and interpreting platelet-leukocyte aggregates.Platelets. 2018 Nov;29(7):677-685. doi: 10.1080/09537104.2018.1430358. Epub 2018 Feb 20. Platelets. 2018. PMID: 29461910 Free PMC article. Review.
-
Changing common sense: Anti-platelet/coagulation therapy against cirrhosis.World J Hepatol. 2015 Jul 8;7(13):1730-4. doi: 10.4254/wjh.v7.i13.1730. World J Hepatol. 2015. PMID: 26167245 Free PMC article.
-
Platelets: No longer bystanders in liver disease.Hepatology. 2016 Nov;64(5):1774-1784. doi: 10.1002/hep.28526. Epub 2016 Apr 7. Hepatology. 2016. PMID: 26934463 Free PMC article. Review.
-
Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.Dig Dis Sci. 2020 Feb;65(2):524-533. doi: 10.1007/s10620-019-05760-x. Epub 2019 Aug 12. Dig Dis Sci. 2020. PMID: 31407130 Free PMC article.
-
Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.Cancer Manag Res. 2018 Aug 15;10:2695-2709. doi: 10.2147/CMAR.S167560. eCollection 2018. Cancer Manag Res. 2018. PMID: 30147368 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical